Bacterial cell surface amphiphiles and periodontal diseases - Study on the role of CD14 molecule in periodontal tissues -

细菌细胞表面两亲物与牙周疾病-CD14分子在牙周组织中的作用研究-

基本信息

  • 批准号:
    10470378
  • 负责人:
  • 金额:
    $ 8.19万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Bacterial cell surface amphiphiles exhibit various biological activities. Endotoxic lipopolysaccharides (LPS) distributed in the outer membrane of gram-negative bacteria and lipoteichoic acid (LTA) distributed in the cell surfaces of gram-positive bacteria are representative bioactive amphiphiles. Bacterial amphiphiles activate host cells such as macrophages through membrane CD14 (mCD14) expressed on cell surfaces. Last year, we demonstrated the presence of two types of human gingival fibroblasts that highly and lowly express mCD14, and the former cells produced interleukin-8 (IL-8) upon stimulation with LPS and lipid A from Enterobacteriaceae. This year, we found that 1. Bacillus subtilis LTA also activated human gingival fibroblasts via mCD14, whereas LTA from oral streptococci such as Streptococcus sanguis and Streptococcus mutans acted as an LPS-antagonist to inhibit IL-8-induction by LPS. 2. The LPS fraction from Prevotella intermedia, periodontal disease-associated bacteria, activated human dental pulp cells that lack mCD14, in a soluble CD14- and nuclear factor AP-1-dependent manner. 3. Furthermore, in collaboration with Prof. Shizuo Akira, Osaka University, we studied the relationship between amphiphiles and the Toll-like receptor (TLR) system, which was recently revealed to be associated with CD14 and is involved in LPS signaling. We revealed that LTA as well as LPS was recognized by TLR4 in contrast to previous reports. We also obtained evidence suggesting that a bioactive glycoprotein, PGP, prepared from P. intermedia, was recognized by TLR2.With the viewpoint that "bacterial products overstimulate the innate immune system, and result in tissue destruction," we would like to reveal how the CD14/TLR system recognizes and responds to microbes in periodontal tissues in relation to the pathogenesis of periodontal diseases.
细菌细胞表面两亲物表现出各种生物学活性。分布在革兰氏阴性细菌的外膜和lipoteichoic酸(LTA)中的内毒性脂多糖(LPS)分布在革兰氏阳性细菌的细胞表面中是代表性的生物活性植物。细菌两亲物通过在细胞表面表达的膜CD14(MCD14)激活宿主细胞,例如巨噬细胞。去年,我们证明了两种类型的人牙龈成纤维细胞,它们高度低,低表达MCD14,而前一个细胞在用肠杆菌科刺激和脂质A刺激后产生了白介素-8(IL-8)。今年,我们发现1。枯草芽孢杆菌LTA还通过MCD14激活了人牙龈成纤维细胞,而口服链球菌的LTA(例如链球菌链球菌和链球菌突变体)充当LPS抗抗酸菌,以抑制IL-8-8诱导IL-8-诱导LPS。 2。以可溶性CD14和核因子AP-1依赖性方式,与Prevotella Intermedia(牙周疾病相关细菌)的LPS分数激活了缺乏MCD14的人类牙髓细胞。 3.此外,与大阪大学的Shizuo Akira教授合作,我们研究了两亲物与Toll-like受体(TLR)系统之间的关系,最近揭示的是与CD14有关,并参与LPS信号。我们透露,与以前的报告相比,TLR4认可了LTA和LPS。我们还获得了证据,表明由P. Intermedia制备的生物活性糖蛋白PGP得到了TLR的认可。与“细菌产物过度刺激了先天性免疫系统”并导致组织破坏的观点,我们希望如何揭示CD14/TLR系统识别和响应对微生物中的cd14/tlr系统的响应,以相关的是段落中的段落中的含量为中期的段落。

项目成果

期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nemoto, E., S. Sugawara, H. Takada, S. Shoji, and H. Horiuchi: "Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components"Infect. Immun.. 67. 6225-6233 (1999)
Nemoto, E.、S. Sugara、H. Takada、S. Shoji 和 H. Horiuchi:“细胞因子和细菌成分刺激后人牙龈成纤维细胞上 CD26/二肽基肽酶 IV 表达增加”感染。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugiyama, A., T. Ogawa, Y. Daihuhara, and H. Takada: "Enhancement of hepatocyte growth factor (scatter factor) production by human gingival fibroblasts in culture stimulated with Porphyromonas gingivalis fimbriae"J. Med. Microbiol.. 49 (in press).
Sugiyama, A.、T. Okawa、Y. Daihuhara 和 H. Takada:“在用牙龈卟啉单胞菌菌毛刺激的培养物中人牙龈成纤维细胞产生肝细胞生长因子(分散因子)的增强”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Endo Y.,S.Sugawara,H.Takada et al.: "Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality : its suppression by LPS pretreatment"British Journal of Pharmacology. 128. 5-12 (1999)
Endo Y.、S.Sukawara、H.Takada 等人:“半乳糖胺增强脂多糖(LPS)诱导的肿瘤坏死因子产生和致死率:LPS 预处理对其的抑制”英国药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugawara S.,H.Takada et al.: "Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner"Infection and Immunity. 67. 1623-1632 (1999)
Sukawara S.、H.Takada 等人:“脂磷壁酸以 CD14 依赖性方式作为人牙龈成纤维细胞和单核细胞上脂多糖的拮抗剂和激动剂”感染和免疫。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsushita, K., T. Tajima, K. Tomita, H. Takada, S. Nagaoka, and M. Torii: "Inflammatory cytokine production and specific antibody responses to lipopolysaccharide from endodontopathic black-pigmented bacteria in patients with multilesional periapical peri
Matsushita, K.、T. Tajima、K. Tomita、H. Takada、S. Nagaoka 和 M. Torii:“多病灶根尖周患者的炎症细胞因子产生和对牙髓病黑色素细菌脂多糖的特异性抗体反应
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKADA Haruhiko其他文献

TAKADA Haruhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKADA Haruhiko', 18)}}的其他基金

Commensalism with oral streotococci: Up-regulation of innate immunity
与口腔链球菌共生:先天免疫的上调
  • 批准号:
    25670794
  • 财政年份:
    2013
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Innate immune system in oral mucosa, with special reference to inhibition of inflammatory and immune responses and up-regulation of antibacterial functions
口腔粘膜的先天免疫系统,特别是抑制炎症和免疫反应以及上调抗菌功能
  • 批准号:
    18390484
  • 财政年份:
    2006
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Innate Immune Response via Intracellular Receptor NODs and Periodontal Diseases
通过细胞内受体 NOD 的先天免疫反应和牙周病
  • 批准号:
    16390519
  • 财政年份:
    2004
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Periodontal Diseases as a Hypersensitivity Reaction Based on Innate Immune Responses in Periodontal Tissues
牙周病是一种基于牙周组织先天免疫反应的超敏反应
  • 批准号:
    14370576
  • 财政年份:
    2002
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Recognition of Cell-Surface Components of Bacteria in Innate Immune System, with Special Reference to the Role of Toll-Like Receptors
先天免疫系统中细菌细胞表面成分的识别,特别是 Toll 样受体的作用
  • 批准号:
    12470380
  • 财政年份:
    2000
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Superantigen Produced by oral Streptococci and oral mucosal diseases.
超抗原由口腔链球菌和口腔粘膜疾病产生。
  • 批准号:
    08457483
  • 财政年份:
    1996
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

去势环境下CAF来源的CREB3L4通过增强癌细胞脂肪酸合成促进前列腺癌转移的机制研究
  • 批准号:
    82303434
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SIRT5驱动心肌脂肪酸代谢重编程在辐射诱导心肌衰老中的机制研究
  • 批准号:
    82360629
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
  • 批准号:
    82300206
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
放射后早期神经元-星形胶质细胞脂肪酸代谢耦联对正常脑组织免疫微环境的重塑及其机制研究
  • 批准号:
    82373516
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
ATP-柠檬酸裂解酶调控脂肪酸合成代谢在苯致造血功能抑制中的作用机制及干预研究
  • 批准号:
    82300143
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Discovery and characterization of bacterial cell envelope assembly and remodeling networks that modulate tolerance to antibiotics
调节抗生素耐受性的细菌细胞包膜组装和重塑网络的发现和表征
  • 批准号:
    10711329
  • 财政年份:
    2023
  • 资助金额:
    $ 8.19万
  • 项目类别:
TREM2 senses both pathogen- and damage-associated molecular patterns to promote S. aureus craniotomy infection
TREM2 感知病原体和损伤相关分子模式以促进金黄色葡萄球菌开颅感染
  • 批准号:
    10425761
  • 财政年份:
    2022
  • 资助金额:
    $ 8.19万
  • 项目类别:
Universal Anti-PAMP Agent to Improve Wound Healing
促进伤口愈合的通用抗 PAMP 剂
  • 批准号:
    10647897
  • 财政年份:
    2022
  • 资助金额:
    $ 8.19万
  • 项目类别:
TREM2 senses both pathogen- and damage-associated molecular patterns to promote S. aureus craniotomy infection
TREM2 感知病原体和损伤相关分子模式以促进金黄色葡萄球菌开颅感染
  • 批准号:
    10672190
  • 财政年份:
    2022
  • 资助金额:
    $ 8.19万
  • 项目类别:
Universal Anti-PAMP Agent to Improve Wound Healing
促进伤口愈合的通用抗 PAMP 剂
  • 批准号:
    10527023
  • 财政年份:
    2022
  • 资助金额:
    $ 8.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了